Aurobindo Pharma Limited

Aurobindo Pharma Limited

Share · INE406A01037 (XBOM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Aurobindo Pharma Limited
No Price
Closing Price XBOM 29.04.2026: 1.395,15 INR
29.04.2026 10:00
Current Prices from Aurobindo Pharma Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
AUROPHARMA.NS
INR
29.04.2026 10:00
1.396,80 INR
-24,50 INR
-1,72 %
XBOM: MSE
MSE
AUROPHARMA.BO
INR
29.04.2026 09:59
1.395,15 INR
-26,15 INR
-1,84 %
Share Float & Liquidity
Free Float 48,03 %
Shares Float 278,94 M
Shares Outstanding 580,8 M
Invested Funds

The following funds have invested in Aurobindo Pharma Limited:

Fund
iShares MSCI India UCITS ETF USD (Acc)
Vol. in million
3.658,91
Percentage (%)
0,31 %
Fund
iShares MSCI EM Islamic UCITS ETF USD (Dist)
Vol. in million
149,92
Percentage (%)
0,14 %
Fund
iShares MSCI EM ex-China UCITS ETF USD (Acc)
Vol. in million
9,49
Percentage (%)
0,06 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
101,24
Percentage (%)
0,03 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
512,51
Percentage (%)
0,03 %
Company Profile for Aurobindo Pharma Limited Share
Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Company Data

Name Aurobindo Pharma Limited
Company Aurobindo Pharma Limited
Website https://www.aurobindo.com
Primary Exchange XBOM MSE
ISIN INE406A01037
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Makkapati Satakarni
Market Capitalization 826 Mrd.
Country India
Currency INR
Employees 26,0 T
Address Galaxy, Plot No. 1, 500032 Hyderabad
IPO Date 2000-01-03

Stock Splits

Date Split
20.07.2015 2:1
10.02.2011 5:1
23.10.2003 2:1
20.03.2000 2:1
15.03.2000 2:1
26.10.1998 2:1

Ticker Symbols

Name Symbol
MSE AUROPHARMA.BO
NSE AUROPHARMA.NS
More Shares
Investors who hold Aurobindo Pharma Limited also have the following shares in their portfolio:
DZ BANK      IS.A2230
DZ BANK IS.A2230 Bond
Opus-Charter.Iss. S.A.Cpmt 144 MEZ Capital LT Opportunity
Opus-Charter.Iss. S.A.Cpmt 144 MEZ Capital LT Opportunity Unbekannt